KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pagaya Technologies (PGY) Research & Development (2023 - 2025)

Pagaya Technologies (PGY) has disclosed Research & Development for 3 consecutive years, with $19.1 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 2.56% to $19.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $75.2 million through Dec 2025, down 1.77% year-over-year, with the annual reading at $75.2 million for FY2025, 1.77% down from the prior year.
  • Research & Development for Q4 2025 was $19.1 million at Pagaya Technologies, up from $18.2 million in the prior quarter.
  • The five-year high for Research & Development was $21.9 million in Q2 2024, with the low at $16.7 million in Q3 2024.
  • Average Research & Development over 3 years is $18.8 million, with a median of $18.5 million recorded in 2024.
  • The sharpest move saw Research & Development increased 24.19% in 2024, then dropped 15.87% in 2025.
  • Over 3 years, Research & Development stood at $17.6 million in 2023, then grew by 5.99% to $18.6 million in 2024, then grew by 2.56% to $19.1 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $19.1 million, $18.2 million, and $18.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.